International Journal of Anesthesia and Critical Care

Letter to the Editor Open Access

Cardiovascular Adverse Events after COVID-19 Vaccination

Miguel J. Mejia Morales , Anjli Maroo , Tariq Kewan , Mahmoud Alwakeel , Mohammed Al-Jaghbeer , Francois Abi Fadel

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global pandemic by the World Health Organization in March 2020 and since then, it has caused huge economic and social turmoil worldwide [1]. In an attempt to reduce the spread across the United States (U.S.) and worldwide, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) of different vaccines (BNT-162b2, mRNA-1273, and Ad26.COV2. S).

Int J Anaesth Crit Care, 2023, Volume 2, Issue 1, p1-4 | DOI: 10.33696/Anesthesia.2.006